International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Allopurinol 20 mg/mL in SyrSpend SF pH4

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2019 - Volume 23, Number 5
View All Articles in Issue

Page(s): 406

Allopurinol 20 mg/mL in SyrSpend SF pH4 Page 1

Download in electronic PDF format for $65

Abstract: A formulation for preparing Allopurinol 20 mg/mL in SyrSpend SF pH4. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, allopurinol, formulation, hyperuricemia, chronic gout, gouty arthritis, gouty nephropathy, recurrent calcium oxalate crystals, cancer chemotherapy

Related Categories: FORMULATIONS, MUSCULOSKELETAL DISORDERS, UROLOGY/URINARY TRACT

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Allopurinol 20 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2019 Pg. 406
Allopurinol Sodium 4-mg/mL Injection Allen Loyd V Jr	Jul/Aug 2013 Pg. 328
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr	Mar/Apr 2004 Pg. 126-129
Stability of Allopurinol Suspension Compounded from Tablets Alexander Kenneth S, Davar Nipun, Parker Gordon A	Mar/Apr 1997 Pg. 128-131
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2 Williams LaVonn A	Jan/Feb 2019 Pg. 14-21
Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A	Sep/Oct 2020 Pg. 413-419
Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	May/Jun 2017 Pg. 233
Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2019 Pg. 53
Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2019 Pg. 490
Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jan/Feb 2021 Pg. 46
Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Allen Loyd V Jr	Nov/Dec 2019 Pg. 488
Allopurinol 20-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 1997 Pg. 174
Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Nov/Dec 2021 Pg. 508
Lorazepam 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Mar/Apr 2022 Pg. 143
Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O	Sep/Oct 2016 Pg. 426-434
Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Allen Loyd V Jr	Jan/Feb 2018 Pg. 55
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2018 Pg. 233